Pharmteco
Scope
Date
~
-
Bio & Pharma
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Dec 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Nov 20, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco to invest $260 mn in new peptide factory in S. Korea
SK Pharmteco, the contract development and manufacturing organization (CDMO) of South Korea's SK Inc., said on Tuesday that it plans to invest $260 ...
Oct 02, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
SK Inc., the holding and investment company of SK Group, South Korea’s second-largest conglomerate, is negotiating to sell a major asset of it...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco launches new viral vector platforms, key for CGT
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco gears up for big leap in advanced biotherapies
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...
Aug 17, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco secures 12 global pharma clients, sets up US R&D center
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...
Aug 09, 2023 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco to raise $500 mn in pre-IPO, aims for 2025 listing
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is set to raise $500 millio...
Jul 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco opens 2nd biomanufacturing plant in France
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured a second plant ...
Jun 23, 2023 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco again seeks $382 mn in pre-IPO funding
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), is eyeing pre-initial public offering funding again after it dropped...
Mar 21, 2023 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco to raise up to $498 mn on $5 bn valuation
SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...
Jan 10, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand